APA aipamena

HE, W., SUN, Z., & LIU, Z. (2015). Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel. Exp Ther Med.

Chicago Style aipamena

HE, WENXING, ZHENGKUI SUN, and ZHIMING LIU. "Silencing of TGM2 Reverses Epithelial to Mesenchymal Transition and Modulates the Chemosensitivity of Breast Cancer to Docetaxel." Exp Ther Med 2015.

MLA aipamena

HE, WENXING, ZHENGKUI SUN, and ZHIMING LIU. "Silencing of TGM2 Reverses Epithelial to Mesenchymal Transition and Modulates the Chemosensitivity of Breast Cancer to Docetaxel." Exp Ther Med 2015.